About Aravis
Aravis is a company based in Switzerland. It operates as a Brokerage / Intermediation. Aravis has completed 1 acquisition, including AGI Therapeutics. Aravis offers products and services including Aravis Growth I.
- Headquarter Switzerland
-
Sectors
Financial ServicesHealthcare Technology Industrial Goods & Manufacturing
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Aravis
Aravis offers a comprehensive portfolio of products and services, including Aravis Growth I.
Growth capital fund for high-tech Swiss companies.
Funding Insights of Aravis
Detailed funding history for Aravis
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Aravis
Aravis has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include AGI Therapeutics.
Investment portfolio details for Aravis
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Drug products for lung-related conditions are developed by the company.
|
Locked | Locked | 2005 | Locked |
Complete acquisition details for Aravis
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Aravis
Detailed financials for Aravis
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Aravis Comparisons
Peer comparison for Aravis
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Aravis
Detailed competitors of Aravis
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Aravis
Complete news archive for Aravis
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aravis
Aravis is headquartered in Switzerland.
Growth capital and active support are offered by Aravis to high-tech companies in Switzerland and Europe. Focus is placed on sectors like biotechnology, digital and creative technologies, and industrial high-tech solutions. Expansion of promising startups is accelerated through strategic advice and investor networks. Investments are managed by Aravis Growth I GP AG, targeting growth-phase companies. International deployment of Swiss innovations is facilitated, while capital is channeled to critical sectors. Economic cycles are balanced, and ESG aspects are integrated throughout the investment process.
Aravis offers Aravis Growth I.
Aravis has made 1 acquisition, including AGI Therapeutics.